Why CAMP4?
Leadership
Investors
About Our Name
RAP Platform
Reg Actuators
Programmable Therapeutics
Publications & Presentations
Pipeline
Newsroom
Join the Adventure
Recent News
July 20, 2022
CAMP4 Secures $100 Million Series B Financing to Accelerate Expansion of its Novel Regulatory RNA-Targeting Platform and Advance Lead Programs into the Clinic
Read More
August 3, 2022
Mountain Climbing: CAMP4 Aims to Scale the Heights of Disease
Read More
Contact Us
Privacy Policy
Menu
Newsroom
Views and missives from the frontier
All
Press Releases
Perspectives
In the News
Videos
July 7, 2022
Perspectives
EPIC proportions of discovery: CAMP4’s AI model for identifying regRNA targets
July 7, 2022
Perspectives
Finding light in the dark side of the genome: CAMP4’s approach to targeting regRNA in genetic diseases
Media Contact:
PR@camp4tx.com
Top
